Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Inflammatory Bowel Disease Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Janssen Pharmaceuticals
Merck
UCB
Galapagos
Akebia Therapeutics
Genentech
Shire
ChemoCentryx
Mitsubishi Tanabe
Novartis
Abbvie
Boehringer Ingelheim
Pfizer
Salix Pharmaceuticals
Biogen Idec
Ferring Pharmaceuticals
By Type:
Parenteral
Oral
By Application:
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Inflammatory Bowel Disease Drugs Market Overview 2018-2029
-
1.1 China Inflammatory Bowel Disease Drugs Industry Development Overview
-
1.2 China Inflammatory Bowel Disease Drugs Industry Development History
-
1.3 China Inflammatory Bowel Disease Drugs Industry Market Size (2018-2029)
-
1.4 China Inflammatory Bowel Disease Drugs Market Analysis by Type from Production Side
-
1.4.1 China Inflammatory Bowel Disease Drugs Production Volume, Production Value and Growth Rate of Parenteral (2018-2029)
-
1.4.2 China Inflammatory Bowel Disease Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
1.5 China Inflammatory Bowel Disease Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Inflammatory Bowel Disease Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Inflammatory Bowel Disease Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Inflammatory Bowel Disease Drugs Market Analysis by Region
-
1.6.1 North China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Inflammatory Bowel Disease Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Inflammatory Bowel Disease Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Inflammatory Bowel Disease Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Inflammatory Bowel Disease Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Inflammatory Bowel Disease Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Inflammatory Bowel Disease Drugs Industry Development
Chapter 3 Inflammatory Bowel Disease DrugsIndustry Chain Analysis
-
3.1 Inflammatory Bowel Disease Drugs Industry Chain
-
3.2 Inflammatory Bowel Disease Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Inflammatory Bowel Disease Drugs Market
-
3.3 Inflammatory Bowel Disease Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Inflammatory Bowel Disease Drugs Market
Chapter 4 China Inflammatory Bowel Disease Drugs Market, by Type
-
4.1 China Inflammatory Bowel Disease Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Inflammatory Bowel Disease Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Inflammatory Bowel Disease Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Inflammatory Bowel Disease Drugs Production Volume and Growth Rate of Parenteral
-
4.5.2 China Inflammatory Bowel Disease Drugs Production Volume and Growth Rate of Oral
Chapter 5 China Inflammatory Bowel Disease Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Inflammatory Bowel Disease Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Inflammatory Bowel Disease Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Inflammatory Bowel Disease Drugs Market Size and Growth Rate of Clinic
-
5.5.2 China Inflammatory Bowel Disease Drugs Market Size and Growth Rate of Hospital
Chapter 6 China Inflammatory Bowel Disease Drugs Market, by Region
-
6.1 China Inflammatory Bowel Disease Drugs Production Volume and Production Value, by Region
-
6.2 China Inflammatory Bowel Disease Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Inflammatory Bowel Disease Drugs Market Analysis
-
7.1 North China Inflammatory Bowel Disease Drugs Market, by Type
-
7.2 North China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 8 Central China Inflammatory Bowel Disease Drugs Market Analysis
-
8.1 Central China Inflammatory Bowel Disease Drugs Market, by Type
-
8.2 Central China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 9 South China Inflammatory Bowel Disease Drugs Market Analysis
-
9.1 South China Inflammatory Bowel Disease Drugs Market, by Type
-
9.2 South China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 10 East China Inflammatory Bowel Disease Drugs Market Analysis
-
10.1 East China Inflammatory Bowel Disease Drugs Market, by Type
-
10.2 East China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 11 Northeast China Inflammatory Bowel Disease Drugs Market Analysis
-
11.1 Northeast China Inflammatory Bowel Disease Drugs Market, by Type
-
11.2 Northeast China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 12 Southwest China Inflammatory Bowel Disease Drugs Market Analysis
-
12.1 Southwest China Inflammatory Bowel Disease Drugs Market, by Type
-
12.2 Southwest China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 13 Northwest China Inflammatory Bowel Disease Drugs Market Analysis
-
13.1 Northwest China Inflammatory Bowel Disease Drugs Market, by Type
-
13.2 Northwest China Inflammatory Bowel Disease Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Janssen Pharmaceuticals
-
14.1.1 Janssen Pharmaceuticals Company Profile
-
14.1.2 Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Merck
-
14.2.1 Merck Company Profile
-
14.2.2 Merck Inflammatory Bowel Disease Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 UCB
-
14.3.1 UCB Company Profile
-
14.3.2 UCB Inflammatory Bowel Disease Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Galapagos
-
14.4.1 Galapagos Company Profile
-
14.4.2 Galapagos Inflammatory Bowel Disease Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Akebia Therapeutics
-
14.5.1 Akebia Therapeutics Company Profile
-
14.5.2 Akebia Therapeutics Inflammatory Bowel Disease Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Genentech
-
14.6.1 Genentech Company Profile
-
14.6.2 Genentech Inflammatory Bowel Disease Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Shire
-
14.7.1 Shire Company Profile
-
14.7.2 Shire Inflammatory Bowel Disease Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 ChemoCentryx
-
14.8.1 ChemoCentryx Company Profile
-
14.8.2 ChemoCentryx Inflammatory Bowel Disease Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Mitsubishi Tanabe
-
14.9.1 Mitsubishi Tanabe Company Profile
-
14.9.2 Mitsubishi Tanabe Inflammatory Bowel Disease Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Novartis
-
14.10.1 Novartis Company Profile
-
14.10.2 Novartis Inflammatory Bowel Disease Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Abbvie
-
14.11.1 Abbvie Company Profile
-
14.11.2 Abbvie Inflammatory Bowel Disease Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Boehringer Ingelheim
-
14.12.1 Boehringer Ingelheim Company Profile
-
14.12.2 Boehringer Ingelheim Inflammatory Bowel Disease Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Pfizer
-
14.13.1 Pfizer Company Profile
-
14.13.2 Pfizer Inflammatory Bowel Disease Drugs Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Salix Pharmaceuticals
-
14.14.1 Salix Pharmaceuticals Company Profile
-
14.14.2 Salix Pharmaceuticals Inflammatory Bowel Disease Drugs Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Biogen Idec
-
14.15.1 Biogen Idec Company Profile
-
14.15.2 Biogen Idec Inflammatory Bowel Disease Drugs Market Performance
-
14.15.3 Product&Service Introduction
-
14.16 Ferring Pharmaceuticals
-
14.16.1 Ferring Pharmaceuticals Company Profile
-
14.16.2 Ferring Pharmaceuticals Inflammatory Bowel Disease Drugs Market Performance
-
14.16.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Inflammatory Bowel Disease Drugs Industry Research Conclusions
-
15.2 Inflammatory Bowel Disease Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Inflammatory Bowel Disease Drugs Industry Market Size (2018-2029)
-
Figure China Inflammatory Bowel Disease Drugs Production Volume, Production Value and Growth Rate of Parenteral (2018-2029)
-
Figure China Inflammatory Bowel Disease Drugs Production Volume, Production Value and Growth Rate of Oral (2018-2029)
-
Figure China Inflammatory Bowel Disease Drugs Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Inflammatory Bowel Disease Drugs Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Inflammatory Bowel Disease Drugs Market Size and Growth Rate from 2018-2029
-
Figure Inflammatory Bowel Disease Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Inflammatory Bowel Disease Drugs Market Share by Type in 2018
-
Figure China Inflammatory Bowel Disease Drugs Market Share by Type in 2023
-
Figure China Inflammatory Bowel Disease Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Production Volume and Growth Rate of Parenteral (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Production Volume and Growth Rate of Oral (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Market Share by Application in 2018
-
Figure China Inflammatory Bowel Disease Drugs Market Share by Application in 2023
-
Figure China Inflammatory Bowel Disease Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Inflammatory Bowel Disease Drugs Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Production Volume by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Production Volume Share by Region (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Production Volume Share by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Production Value by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Production Value Share by Region (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Production Value Share by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Sales Volume by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Sales Volume Share by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Sales Value by Region (2018-2023)
-
Table China Inflammatory Bowel Disease Drugs Sales Value Share by Region (2018-2023)
-
Figure China Inflammatory Bowel Disease Drugs Sales Value Share by Region (2018-2023)
-
Table North China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table North China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table North China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table North China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table Central China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table Central China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table South China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table South China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table South China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table East China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table East China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table East China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Inflammatory Bowel Disease Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Inflammatory Bowel Disease Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Inflammatory Bowel Disease Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Inflammatory Bowel Disease Drugs Sales Volume Share by Application (2018-2023)
-
Table Janssen Pharmaceuticals Company Profile
-
Table Janssen Pharmaceuticals Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table UCB Company Profile
-
Table UCB Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Galapagos Company Profile
-
Table Galapagos Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Akebia Therapeutics Company Profile
-
Table Akebia Therapeutics Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Genentech Company Profile
-
Table Genentech Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table ChemoCentryx Company Profile
-
Table ChemoCentryx Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Mitsubishi Tanabe Company Profile
-
Table Mitsubishi Tanabe Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Abbvie Company Profile
-
Table Abbvie Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Salix Pharmaceuticals Company Profile
-
Table Salix Pharmaceuticals Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Biogen Idec Company Profile
-
Table Biogen Idec Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
Table Ferring Pharmaceuticals Company Profile
-
Table Ferring Pharmaceuticals Inflammatory Bowel Disease Drugs Revenue, Price and Gross (2018-2023)
-
